Medicure (TSE:MPH) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medicure Inc. has signed an agreement to acquire intellectual property from CanAm Bioresearch Inc., focusing on new chemical entities with potential therapeutic applications. The deal includes an initial cash payment and additional milestone payments upon filing and approval of new drug applications. Medicure expects these acquisitions to enhance its pharmaceutical development and commercialization efforts in the United States.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.